Key result
Coxsackievirus B infection may trigger type 1 diabetes through direct beta-cell death, secondary T-cell responses, or epitope mimicry, though definitive causal evidence in humans remains elusive.
Why the study?
Despite increasing evidence linking CVB infection to type 1 diabetes, demonstrating causality remains elusive and information regarding antiviral immune responses triggered by infection is scarce.
Understanding the mechanisms of CVB-induced beta-cell death is critical for maximizing the success of emerging CVB vaccines for type 1 diabetes prevention.
No takes yet. Share an insight, caveat, or question.
Accumulating observational data link CVB to T1D; leaves open causality and prevention potential until vaccine trials report.
Carré et al. (2023) conducted a review in Type 1 Diabetes. Coxsackievirus B (CVB) infection was evaluated. Coxsackievirus B infection may trigger type 1 diabetes through direct beta-cell death, secondary T-cell responses, or epitope mimicry, though definitive causal evidence in humans remains elusive.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: